Revance alert: bragar eagel & squire, p.c. is investigating revance therapeutics, inc. on behalf of long-term stockholders and encourages investors to contact the firm

New york, march 06, 2025 (globe newswire) -- bragar eagel & squire, p.c., a nationally recognized shareholder rights law firm, is investigating potential claims against revance therapeutics, inc. (nasdaq:rvnc) on behalf of long-term stockholders following a class action complaint that was filed against revance on january 3, 2025 with a class period from february 29, 2024 to december 6, 2024. our investigation concerns whether the board of directors of revance have breached their fiduciary duties to the company.
RVNC Ratings Summary
RVNC Quant Ranking